Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of C$0.13 and traded as high as C$0.14. Voyageur Pharmaceuticals shares last traded at C$0.14, with a volume of 183,860 shares changing hands.
Voyageur Pharmaceuticals Stock Down 3.7%
The firm’s 50 day moving average is C$0.14 and its 200-day moving average is C$0.13. The firm has a market cap of C$29.59 million, a PE ratio of -6.50 and a beta of 0.66. The company has a quick ratio of 0.84, a current ratio of 3.05 and a debt-to-equity ratio of 0.95.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
